ArticleBritish journal of cancer2020

miR-622 is a novel potential biomarker of breast carcinoma and impairs motility of breast cancer cells through targeting NUAK1 kinase.

Francesca Maria Orlandella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.